Paul Damon & Associates, Inc. Pfizer Inc Transaction History
Paul Damon & Associates, Inc.
- $191 Billion
- Q2 2025
A detailed history of Paul Damon & Associates, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Paul Damon & Associates, Inc. holds 30,610 shares of PFE stock, worth $732,497. This represents 0.39% of its overall portfolio holdings.
Number of Shares
30,610Holding current value
$732,497% of portfolio
0.39%Shares
1 transactions
Others Institutions Holding PFE
# of Institutions
3,341Shares Held
3.6BCall Options Held
104MPut Options Held
129M-
Vanguard Group Inc Valley Forge, PA523MShares$12.5 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY424MShares$10.2 Billion0.27% of portfolio
-
State Street Corp Boston, MA297MShares$7.11 Billion0.32% of portfolio
-
Geode Capital Management, LLC Boston, MA126MShares$3.01 Billion0.26% of portfolio
-
Wellington Management Group LLP Boston, MA103MShares$2.48 Billion0.52% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $134B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...